Number of the records: 1  

Genetically modified cellular vaccines against human papillomavirus type 16 (HPV16)-associated tumors: adjuvant treatment of minimal residual disease after surgery/chemotherapy

  1. 1.
    Bubeník, Jan - Šímová, Jana
    Genetically modified cellular vaccines against human papillomavirus type 16 (HPV16)-associated tumors: adjuvant treatment of minimal residual disease after surgery/chemotherapy.
    Journal of Balkan Union of Oncology. Roč. 14, č. 1 (2009), s. 169-173. ISSN 1107-0625. E-ISSN 2241-6293
    Impact factor: 0.600, year: 2009
    http://hdl.handle.net/11104/0187687
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.